Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
12.82
-0.47 (-3.54%)
At close: Jul 1, 2026, 4:00 PM EDT
12.83
+0.01 (0.08%)
Pre-market: Jul 2, 2026, 8:36 AM EDT
Evommune Market Cap
Evommune has a market cap or net worth of $461.76 million as of July 2, 2026.
Market Cap
461.76M
Enterprise Value
259.41M
1-Year Change
n/a
Ranking
Category
Stock Price
$12.82
Market Cap Chart
Since the IPO on November 6, 2025, Evommune's market cap has decreased from $481.24M to $461.76M, a decrease of -4.05%. That is a compound annual growth rate of -6.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 461.76M | -14.44% |
| Dec 31, 2025 | 539.69M | 12.15% |
| Nov 6, 2025 | 481.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 495.96M |
| Cabaletta Bio | 487.53M |
| Prelude Therapeutics | 486.96M |
| Valneva SE | 485.57M |
| C4 Therapeutics | 479.86M |
| Artiva Biotherapeutics | 476.16M |
| Zura Bio | 475.46M |
| Sagimet Biosciences | 460.67M |